Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses

Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses

US Patent 9518127 · Granted Dec 13, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods to improve exercise performance and recovery2024
Nucleic acids encoding antibodies against human granulocyte-colony stimulating f2024
Nucleic acids encoding antibodies against human granulocyte-colony stimulating f2024
Therapy using a factor XII inhibitor in a neurotraumatic disorder2024
CD131 binding proteins and uses thereof2023
CD131 binding proteins and uses thereof2023
Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidne2022
Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidne2022
Human serum albumin variants and uses thereof2022
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies2022
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies2022
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies2022